Clinical observation of oxytocin combined with prostaglandins in prevention of postpartum hemorrhage of high-risk pregnancy puerperae with caesarean section
Li LI,Xiu-hong YUAN,Xiao-mei LUO,Hong-mei LI,Liang CHEN
DOI: https://doi.org/10.7501/j.issn.1674-5515.2014.06.009
2014-01-01
Abstract:Objective To investigate the clinical efficacy of oxytocin combined with prostaglandins in the prevention of postpartum hemorrhage of high-risk pregnancy puerperae with caesarean section. Methods High-risk pregnancy puerperae(330 cases) with caesarean section in Affiliated Hospital of Yan'an University from January 2012 to December 2013 were randomly divided into 3 groups(110 cases in each group). They were carboprost tromethamine combined with oxytocin(CTO) group, carboprost methylate combined with oxytocin(CMO) group, and oxytocin group. And patients in the CTO group were im given carboprost tromethamine 250 μg in the body of uterus following fetus expulsion, and then were iv oxytocin 10 U. The patients in the CMO group were sublingual administered with carboprost methylate 1 mg following fetus expulsion, and were iv oxytocin 10 U. The patients in the oxytocin group were iv oxytocin 10 U following fetus expulsion, and were im given oxytocin 10 U in body of uterus. The quantity of bleeding was compared among the three groups during the operation, 2, and 2 – 4 h after operation. The postpartum hemorrhage, blood transfusion, and additional hemostatic measures after delivery were observed among the three groups. The side reaction was also observed among the three groups. Results During operation, 2, and 2 – 4 h after operation, the quantity of bleeding of maternal in the CTO group was less than that in the CMO group and oxytocin group, with the significant difference(P 0.05). During the operation, 2 h after operation, the quantity of bleeding of maternal in the CMO group was significantly less than that in the oxytocin group(P 0.05). While 2 – 4 h after the operation, there was no significant difference. The postpartum hemorrhage, blood transfusion rate, and additional intervention measures to stop bleeding in the CTO and CMO groups were significantly lower than those in the oxytocin group(P 0.05). The side effects of the three groups were 9.09%, 8.18%, and 6.36%, respectively, and there was no significant difference. Conclusion CTO is effective in preventing postpartum hemorrhage of high-risk pregnancy. CMO could reach a certain preventive effect, but the application of oxytocin simply is poor efficacy.